...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Thoughts on ZCC

KBC - I agree with what you say but still feel DM has to wear it because he won't tell us what is holding it up. Being this far behind what he told us warrants an explanation rather than saying any day and then it still doesn't happen. If there is a reason other than his ineptitude, clarify the situation. The dire financial situation which is his responsibility, no milestones or promises being met and lack of information is driving this stock to oblivion and causing enormous dilution in financings. Come clean, we deserve more than he is offering so he has to wear it.

Share
New Message
Please login to post a reply